Human exposure to synthetic endocrine disrupting chemicals (S-EDCs) is generally negligible as compared to natural compounds with higher or comparable endocrine activity. How to evaluate the risk of the S-EDCs?

References

• Adler, S., D. Basketter, S. Creton, O. Pelkonen, J. van Benthem, V. Zuang, K.E. Andersen, A. Angers-Loustau, A. Aptula, and A. Bal-Price, et al. 2011. Alternative (non-animal) methods for cosmetics testing: current status and future prospects-2010. Arch Toxicol 85:367-485.
   PubMed Web of Science ®Google Scholar
• Autrup, H., F. A. Barile, B. J. Blaauboer, G. H. Degen, W. Dekant, D. Dietrich, J. L. Domingo, G. B. Gori, H. Greim, J. G. Hengstler, et al. 2015. Principles of pharmacology and toxicology also govern effects of chemicals on the endocrine system. Toxicological Sciences 146 (1):11–15. doi:10.1093/toxsci/kfv082.
   PubMed Web of Science ®Google Scholar
• Autrup, H., F. A. Barile, B. J. Blaauboer, G. H. Degen, W. Dekant, D. Dietrich, J. L. Domingo, G. B. Gori, H. Greim, J. G. Hengstler, et al. 2016a. Response to “the path forward on endocrine disruptors requires focus” by Zoeller et al. Toxicol. Sci. 149:273–74.
   PubMed Web of Science ®Google Scholar
• Autrup, H. N., S. C. Berry, S. M. Cohen, E. E. Creppy, J. L. de Camargo, W. Dekant, D. Dietrich, C. L. Galli, J. I. Goodman, G. B. Gori, et al. 2016b. Whither the impending european regulation of presumed endocrine disruptors? Regul. Toxicol. Pharmacol. 82:A1–A2. doi:10.1016/j.yrtph.2016.09.006.
   PubMed Web of Science ®Google Scholar
• Bolt, H. M., P. Janning, H. Michna, and G. H. Degen. 2001. Comparative assessment of endocrine modulators with oestrogenic activity: I. Definition of a hygiene-based margin of safety (HBMOS) for xeno-oestrogens against the background of European developments. Arch. Toxicol. 74:649–62.
   PubMed Web of Science ®Google Scholar
• Borgert, C. J., E. V. Sargent, G. Casella, D. R. Dietrich, L. S. McCarty, and R. J. Golden. 2012. The human relevant potency threshold: Reducing uncertainty by human calibration of cumulative risk assessments. Regul. Toxicol. Pharmacol. 62:313–28. doi:10.1016/j.yrtph.2011.10.012.
   PubMed Web of Science ®Google Scholar
• Borgert, C. J., J. C. Matthews, and S. P. Baker. 2018. Human-relevant potency threshold (HRPT) for ERalpha agonism. Arch. Toxicol. 92:1685–702. doi:10.1007/s00204-018-2186-z.
   PubMed Web of Science ®Google Scholar
• Borgert, C. J., S. P. Baker, and J. C. Matthews. 2013. Potency matters: Thresholds govern endocrine activity. Regul. Toxicol. Pharmacol. 67:83–88. doi:10.1016/j.yrtph.2013.06.007.
   PubMed Web of Science ®Google Scholar
• Caldwell, D. J., F. Mastrocco, P. D. Anderson, R. Lange, and J. P. Sumpter. 2012. Predicted-no-effect concentrations for the steroid estrogens estrone, 17beta-estradiol, estriol, and 17alpha-ethinylestradiol. Environ. Toxicol. Chem. 31:1396–406. doi:10.1002/etc.1825.
   PubMed Web of Science ®Google Scholar
• Cassidy, A. 1998. Risks and benefits of phytoestrogen-rich diets. In Symposium: Hormonally active agents in food, organized by the DFG senate commission of food Safety. Kaiserslautern, october 6-9th, ed. G. Eisenbrand, H. Daniel, A. D. Dayan, P. S. Elias, W. Grunow, F. H. Kemper, E. Löser, M. Metzler, and J. Schlatter, 91–117.
   Google Scholar
• Cleve, A., K. H. Fritzemeier, B. Haendler, N. Heinrich, C. Moller, W. Schwede, and T. Wintermantel. 2012. Pharmacology and clinical use of sex steroid hormone receptor modulators. In Handb exp pharmacol, 543–87.
   Google Scholar
• Collins, D., W. Jacob, J. M. Cejalvo, M. Ceppi, I. James, M. Hasmann, J. Crown, A. Cervantes, M. Weisser, and B. Bossenmaier. 2017. Direct estrogen receptor (ER)/HER family crosstalk mediating sensitivity to lumretuzumab and pertuzumab in ER+ breast cancer. PLoS ONE 12:e0177331. doi:10.1371/journal.pone.0177331.
   PubMed Web of Science ®Google Scholar
• Dekant, W., and T. Colnot. 2013. Endocrine effects of chemicals: Aspects of hazard identification and human health risk assessment. Toxicol. Lett. 223:280–86. doi:10.1016/j.toxlet.2013.03.022.
   PubMed Web of Science ®Google Scholar
• Dietrich, D., and J. Hengstler. 2016. From bisphenol A to bisphenol F and a ban of mustard due to chronic low-dose exposures? Arch. Toxicol. 90:489–91. doi:10.1007/s00204-016-1671-5.
   PubMed Web of Science ®Google Scholar
• Dietrich, D., S. von Aulock, H. W. Marquardt, B. J. Blaauboer, W. Dekant, J. Kehrer, J. G. Hengstler, A. C. Collier, G. B. Gori, O. Pelkonen, et al. 2013a. Open letter to the European commission: Scientifically unfounded precaution drives European commission’s recommendations on EDC regulation, while defying common sense, well-established science, and risk assessment principles. Arch. Toxicol. 87:1739–41. doi:10.1007/s00204-013-1117-2.
   PubMed Web of Science ®Google Scholar
• Dietrich, D. R. 2010. Courage for simplification and imperfection in the 21st century assessment of “endocrine disruption”. ALTEX 27:264–78. doi:10.14573/altex.2010.4.264.
   PubMedGoogle Scholar
• Dietrich, D. R., S. von Aulock, H. Marquardt, B. Blaauboer, W. Dekant, J. Hengstler, A. Collier, G. B. Gori, O. Pelkonen, F. Lang, et al. 2013b. Editorial. Regul. Toxicol. Pharmacol. 67:317–20.
   PubMedGoogle Scholar
• Dietrich, D. R., W. Dekant, H. Greim, P. Heslop-Harrison, S. C. Berry, A. Boobis, J. Hengstler, and R. Sharpe. 2016. Allowing pseudoscience into EU risk assessment processes is eroding public trust in science experts and in science as a whole: The bigger picture. Chem. Biol. Interact. 257:1–3. doi:10.1016/j.cbi.2016.07.023.
   PubMed Web of Science ®Google Scholar
• EFSA. 2013. Scientific opinion on the hazard assessment of endocrine disruptors: Scientific criteria for identification of endocrine disruptors and appropriateness of existing test methods for assessing effects mediated by these substances on human health and the environment. Efsa J. 2013 11(3):3132.
   Google Scholar
• EU-SCCS, 2014. Memorandum on endocrine disruptors of the scientific committee on consumer safety (SCCS) adopted at its 8th plenary meeting on 16 December 2014 (SCCS/1544/14).
   Google Scholar
• EU-SCSTEE, 1999. CSTEE opinion on human and wildlife health effects of endocrine disrupting chemicals, with emphasis on wildlife and on a ecotoxicology test methods expressed at the 8th CSTEE plenary meeting, brussels, 4 march 1999. Report of the Working Group on Endocrine Disrupters of the Scientific Committee on Toxicity, Ecotoxicity and the Environment (CSTEE) of DG XXIV, Consumer Policy and Consumer Health Protection.
   Google Scholar
• Golden, R., J. Gandy, and G. Vollmer. 2005. A review of the endocrine activity of parabens and implications for potential risks to human health. Crit. Rev. Toxicol. 35:435–58. doi:10.1080/10408440490920104.
   PubMed Web of Science ®Google Scholar
• Golden, R. J., K. L. Noller, L. Titus-Ernstoff, R. H. Kaufman, R. Mittendorf, R. Stillman, and E. A. Reese. 1998. Environmental endocrine modulators and human health: An assessment of the biological evidence. Crit. Rev. Toxicol. 28:109–227.
   PubMed Web of Science ®Google Scholar
• Gori, G. B., and W. Dekant. 2016. Deepening uncertainty on how the EU may regulate supposable endocrine disruptors. Regulatory Toxicology and Pharmacology 81:8–9. doi:10.1016/j.yrtph.2016.06.020.
   PubMed Web of Science ®Google Scholar
• Irvine, C. H., M. G. Fitzpatrick, and S. L. Alexander. 1998. Phytoestrogens in soy-based infant foods: Concentrations, daily intake, and possible biological effects. Proc. Soc. Exp. Biol. Med. 217:247–53. doi:10.3181/00379727-217-44229.
   PubMed Web of Science ®Google Scholar
• Karwacka, A., D. Zamkowska, M. Radwan, and J. Jurewicz. 2019. Exposure to modern, widespread environmental endocrine disrupting chemicals and their effect on the reproductive potential of women: An overview of current epidemiological evidence. Hum Fertil (Camb) 22:2–25. doi:10.1080/14647273.2017.1358828.
   PubMed Web of Science ®Google Scholar
• Leffers, H., M. Naesby, B. Vendelbo, N. E. Skakkebaek, and M. Jorgensen. 2001. Oestrogenic potencies of zeranol, oestradiol, diethylstilboestrol, bisphenol-A and genistein: Implications for exposure assessment of potential endocrine disrupters. Hum. Reprod. 16:1037–45. doi:10.1093/humrep/16.5.1037.
   PubMed Web of Science ®Google Scholar
• Marty, M. S., E. W. Carney, and J. C. Rowlands. 2011. Endocrine disruption: Historical perspectives and its impact on the future of toxicology testing. Toxicol. Sci. 120 (Suppl 1):S93–108. doi:10.1093/toxsci/kfq329.
   PubMedGoogle Scholar
• Menegola, E., M. L. Broccia, F. Di Renzo, and E. Giavini. 2006. Postulated pathogenic pathway in triazole fungicide induced dysmorphogenic effects. Reprod. Toxicol. 22:186–95. doi:10.1016/j.reprotox.2006.04.008.
   PubMed Web of Science ®Google Scholar
• Miller, K. K., N. Al-Rayyan, M. M. Ivanova, K. A. Mattingly, S. L. Ripp, C. M. Klinge, and R. A. Prough. 2013. DHEA metabolites activate estrogen receptors alpha and beta. Steroids 78:15–25. doi:10.1016/j.steroids.2012.10.002.
   PubMed Web of Science ®Google Scholar
• Minguez-Alarcon, L., and A. J. Gaskins. 2017. Female exposure to endocrine disrupting chemicals and fecundity: A review. Curr. Opin. Obstet. Gynecol. 29:202–11. doi:10.1097/GCO.0000000000000373.
   PubMed Web of Science ®Google Scholar
• Nilsson, R. 2000. Endocrine modulators in the food chain and environment. Toxicol Pathol 28:420–31. doi:10.1177/019262330002800311.
   PubMed Web of Science ®Google Scholar
• Nohynek, G. J., C. J. Borgert, D. Dietrich, and K. K. Rozman. 2013. Endocrine disruption: Fact or urban legend? Toxicol. Lett. 223:295–305. doi:10.1016/j.toxlet.2013.10.022.
   PubMed Web of Science ®Google Scholar
• NTP-CERHR, 2007. NTP-CERHR Expert Panel Report on the reproductive and developmental toxicity of bisphenol A. National Toxicology Program.
   Google Scholar
• Patisaul, H. B., and W. Jefferson. 2010. The pros and cons of phytoestrogens. Front Neuroendocrinol 31:400–19. doi:10.1016/j.yfrne.2010.03.003.
   PubMed Web of Science ®Google Scholar
• Rietjens, I., J. Louisse, and K. Beekmann. 2017. The potential health effects of dietary phytoestrogens. Br. J. Pharmacol. 174:1263–80. doi:10.1111/bph.13622.
   PubMed Web of Science ®Google Scholar
• Safe, S. H. 1995. Environmental and dietary estrogens and human health: Is there a problem? Environ. Health Perspect. 103:346–51. doi:10.1289/ehp.95103346.
   PubMed Web of Science ®Google Scholar
• Safe, S. H. 2000. Endocrine disruptors and human health–is there a problem? An update. Environ. Health Perspect. 108:487–93. doi:10.1289/ehp.00108487.
   PubMed Web of Science ®Google Scholar
• Sifakis, S., V. P. Androutsopoulos, A. M. Tsatsakis, and D. A. Spandidos. 2017. Human exposure to endocrine disrupting chemicals: Effects on the male and female reproductive systems. Environ. Toxicol. Pharmacol. 51:56–70. doi:10.1016/j.etap.2017.02.024.
   PubMed Web of Science ®Google Scholar
• Smith, C. J., T. A. Perfetti, A. W. Hayes, and S. C. Berry. 2020. Clinical epidemiology studies on potential effects of endocrine disrupting chemicals should exclude obesity subjects.
   Google Scholar
• Swaen, G. M. H., P. Boffetta, and M. Zeegers. 2018. Impact of changes in human reproduction on the incidence of endocrine-related diseases. Crit. Rev. Toxicol. 48:789–95. doi:10.1080/10408444.2018.1541073.
   PubMed Web of Science ®Google Scholar
• van Ravenzwaay, B., W. Dekant, and H. Vrijhof. 2013. Risk assessment of endocrine disrupting chemicals–introduction to this special issue. Toxicol. Lett. 223:269–70. doi:10.1016/j.toxlet.2013.10.006.
   PubMed Web of Science ®Google Scholar
• Witorsch, R. J. 2002. Endocrine disruptors: Can biological effects and environmental risks be predicted? Regul. Toxicol. Pharmacol. 36:118–30. doi:10.1006/rtph.2002.1564.
   PubMed Web of Science ®Google Scholar
• Witorsch, R. J., and J. A. Thomas. 2010. Personal care products and endocrine disruption: A critical review of the literature. Crit. Rev. Toxicol. 40 (Suppl 3):1–30. doi:10.3109/10408444.2010.515563.
   PubMed Web of Science ®Google Scholar
• Zamkowska, D., A. Karwacka, J. Jurewicz, and M. Radwan. 2018. Environmental exposure to non-persistent endocrine disrupting chemicals and semen quality: An overview of the current epidemiological evidence. Int. J. Occup. Med. Environ. Health 31:377–414. doi:10.13075/ijomeh.1896.01195.
   PubMed Web of Science ®Google Scholar